Joint WHO-DNDi meeting on fostering the development and rational use of new antibiotics:how a product development partnership could promote innovation and responsible access to new antibiotics
As a follow up to the WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation that took place on 13 May 2014, WHO and the Drugs for Neglected Diseases initiative (DNDi) jointly organized a two-day technical consultation on 8 and 9 December 2014 in Geneva on research and development of new antibiotics. Growing antibiotic resistance globally and the low level of investment in R&D on antibiotics is increasingly considered one of the biggest global health threats. The objective of the meeting was to explore the potential need for a product development partnership to promote innovation and responsible access to new antibiotics.